期刊文献+

他汀类药物与痴呆 被引量:16

Statins and Dementia
下载PDF
导出
摘要 他汀类药物已在临床广泛使用,除降血脂作用外,其对痴呆的防治作用正逐渐引起人们的关注。在中年人中高胆固醇血症可能与痴呆呈正相关,而在老年人中则呈负相关。他汀类药物可能通过调节脑内胆固醇代谢、抑制载脂蛋白E表达、减少β淀粉样蛋白形成、降低卒中风险和增强胆碱能神经元功能等机制起到防治痴呆的作用。 Statins have been widely used clinically, apart from lowing serum cholesterol, their effect of prevention and treatment of dementia is arousing general concern. Hypercholesterolemia in middle-aged adults may have positive correlation with dementia, while in the elderly may have negative correlation with dementia. Statins may prevent dementia through several mechanisms, such as regulation of cholesterol metabolism, inhibition of apolipoprotein E expression, inhibition of β-amyloid formation, reduction of stroke risk, and enhancement of cholinergic neuronal function.
作者 林岩 李焰生
出处 《国外医学(脑血管疾病分册)》 2005年第9期689-693,共5页 Foreign Medical Sciences Cerebrovascular Diseases
基金 上海市科委重大攻关项目(03DZ19704)
关键词 他汀类 痴呆 血管性痴呆 血脂 ALZHEIMER病 statins dementia vascular dementia lipid Alzheimer's disease
  • 相关文献

参考文献29

  • 1Bjorkhem I, Meaney S. Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol, 2004, 24:806-815.
  • 2Locatelli S, Lutjohann D, Schmidt HH. Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain. Arch Neurol, 2002, 59:213-216.
  • 3Vega GL, Weiner MF, Lipton AM, et al. Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease. Arch Neurology, 2003, 60:510-515.
  • 4Casserly I, Topol E. Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins. Lancet,2004, 363:1139-1146.
  • 5Elkins JS, O'Meara ES, Longstreth WT Jr, et al. Stroke risk factors and loss of high cognitive function. Neurology, 2004, 63: 793-799.
  • 6de la Torre JC. Alzheimer disease as a vascular disorder: nosological evidence. Stroke, 2002, 33: 1152-1162.
  • 7Whitmer RA, Sidney S, Selby J, et al. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology, 2005, 64:277-281.
  • 8Reitz C, Tang MX, Luchsinger J, et al. Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol, 2004, 61:705-714.
  • 9Dufouil C, Richard F, Fievet N, et al. APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. Neurology, 2005, 64:1531-1538.
  • 10Rodiguez EG, Dodge HH, Birzescu MA, et al. Use of lipid-lowering drugs in older adults with and without dementia: a community-based epidemiological study. J Am Geriatr Soc, 2002, 50:1852-1856.

同被引文献307

引证文献16

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部